Finance

Lists
Why is CRTX down 5,56%?
Dive Deeper
CRTX:LON
CRISM' Therapeutics Corp
8,50 GBX
-5,56%
(-0,50) 1D
16-окт., 16:30:00 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for CRTX...
Open
8,50 GBX
High
8,50 GBX
Low
8,50 GBX
Mkt. cap
6,73 млн
Avg. vol.
79,56 миң
Volume
12,50 миң
52-wk high
18,50 GBX
52-wk low
8,00 GBX
EPS
-0,05 GBX
Shares outstanding
79,19 млн
No. of employees
0
Open
8,50 GBX
High
8,50 GBX
Low
8,50 GBX
Mkt. cap
6,73 млн
Avg. vol.
79,56 миң
Volume
12,50 миң
52-wk high
18,50 GBX
52-wk low
8,00 GBX
EPS
-0,05 GBX
Shares outstanding
79,19 млн
No. of employees
0
News stories
From web sources and news partners
About CRISM' Therapeutics Corp
CEORobin J. Young
Employees0
Founded2016
Headquarters-
Sector-
Previous reports
Loading Previous Earnings...
Revenue
Net income
All values in GBP
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
115,50 миң
115,50 миң
60,50 миң
60,50 миң
Cost of goods sold
48,50 миң
48,50 миң
14,50 миң
14,50 миң
Cost of revenue
48,50 миң
48,50 миң
14,50 миң
14,50 миң
Research and development expenses
454,00 миң
454,00 миң
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
73,50 миң
73,50 миң
760,00 миң
760,00 миң
Operating expense
552,00 миң
552,00 миң
760,00 миң
760,00 миң
Total operating expenses
600,50 миң
600,50 миң
774,50 миң
774,50 миң
Operating income
-485,00 миң
-485,00 миң
-714,00 миң
-714,00 миң
Other non operating income
-
-
-
-
EBT including unusual items
-485,00 миң
-485,00 миң
-714,00 миң
-714,00 миң
EBT excluding unusual items
-485,00 миң
-485,00 миң
-714,00 миң
-714,00 миң
Income tax expense
-1,00 миң
-1,00 миң
-5,00 миң
-5,00 миң
Effective tax rate
0,21%
0,21%
0,70%
0,70%
Other operating expenses
16,00 миң
16,00 миң
-
-
Net income
-486,50 миң
-486,50 миң
-706,50 миң
-706,50 миң
Net profit margin
-421,21%
-421,21%
-1 167,77%
-1 167,77%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
8,50 миң
8,50 миң
-
-
EBITDA
-480,50 миң
-480,50 миң
-709,50 миң
-709,50 миң
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору